ClinicalTrials.gg
Not yet recruitingNCT07926646Updated Nov 9, 2026

Risk of Caries and Enamel Abnormalities in Patients With Cleft Palate

An interventional study of Clinical oral examination and standardised questionnaires in Dental Caries, sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain. Not yet recruiting at 1 site in Belgium. Open to participants aged 2 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Not applicable, Interventional, and Prevention

Updated Nov 9, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
400
Allocation
Non-randomized
Ages
2 Years to 18 Years
Sex
All
01

Study summary

The goal of this interventional (non-drug, non-device) clinical study is to learn whether children and adolescents born with a cleft lip and/or palate have more tooth decay (dental caries) and more defects of the tooth enamel than children without a cleft, and whether these problems are linked to the type of cleft and to the surgeries these patients have received. In other words, the study aims to find out whether children whose cleft involves the lip and/or the alveolus (the tooth-bearing part of the upper jaw) have a higher risk of caries in the front teeth of the upper jaw.

The main questions it aims to answer are:

Do children with a cleft have a higher caries experience and a higher caries risk than children of the same age without a cleft? In other words, do children with a cleft involving the lip and/or the alveolus have a higher caries risk in the upper front (maxillary anterior) teeth? Are enamel defects (such as hypomineralisation or hypoplasia) more frequent in children with a cleft, where in the mouth are they mainly located, and are they associated with the cleft type or with specific surgical procedures? Do factors such as parental education level, eating habits, oral hygiene habits and the mobility of the scarred upper lip influence the number and the location of caries lesions? Researchers will compare about 200 patients aged 2 to 18 years with any type of cleft (isolated cleft lip, isolated cleft palate, or cleft lip and alveolus with or without cleft palate; with or without an associated syndrome), followed at the Cleft Lip and Palate Centre of the Cliniques universitaires Saint-Luc (Brussels, Belgium), with about 200 children and adolescents of the same age (plus or minus 1 year) without a cleft or syndrome, seen for a routine visit in the paediatric dentistry department of the same hospital.

No drug, device or treatment is tested, and participants' usual care will not be changed. The study adds standardised questionnaires and study-specific clinical assessments to a dental visit that is already planned as part of their regular follow-up. During this visit, participants will:

Have a standard oral examination to record decayed D, missing M and filled F teeth T (DMFT index) in primary and permanent teeth; Have their teeth screened for enamel defects using a standardised European method ( Developmental Defects of Enamel Index ); Have the mobility of their upper lip assessed with a clinical scale (cleft group only), because surgical scars can make brushing of the front teeth more difficult; Possibly have intra-oral photographs taken to document the findings (dental X-rays are only taken if clinically needed for their usual care, never for the study alone).

Parents or legal guardians will fill in short questionnaires about the child's medical and dental history, oral hygiene and eating habits, exposure to protective and risk factors for caries (CAMBRA Caries Management by Risk Assessment), and early-life factors that may be associated with enamel defects.

Participation takes place in a single visit and does not require any additional appointment. There is no direct individual benefit for participants, and the risks are minimal because only routine examinations and questionnaires are used. The results are expected to help identify children with a cleft who are at high risk of caries early on, to show which teeth are most vulnerable, and to design prevention strategies better adapted to these patients (for example, oral hygiene advice and tools adapted to the scarred upper lip).

02

Conditions studied

  • Dental Caries

Keywords

  • Dental Caries
  • Dental Enamel Hypoplasia
  • Molar Incisor Hypomineralization
  • Developmental Defects of Enamel
  • Cleft lip and or palate
  • Cleft lip
  • Cleft palate
03

In context

Dental Caries

1,171 studies on the registry are indexed under Dental Caries; 209 are open to participants now.

This study's planned enrollment of 400 is above the median of 60 across 967 interventional studies indexed under Dental Caries.

Browse Dental Caries studies →

Lead sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain is the lead sponsor of 350 studies on the registry; 64 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Cleft group:

  • Children and adolescents aged 2 to 18 years
  • Any cleft phenotype (isolated cleft lip, isolated cleft palate, cleft lip and alveolus, cleft lip and palate), unilateral (left or right) or bilateral
  • With or without an associated syndrome
  • Primary and/or permanent teeth present
  • Followed at the Cleft Lip and Palate Centre of the Cliniques universitaires Saint-Luc

Control group:

  • Healthy children and adolescents aged 2 to 18 years
  • No cleft lip and/or palate
  • Followed at the Cliniques universitaires Saint-Luc (paediatric dentistry, routine annual check-up or consultation within the Institute of Dental Medicine and Stomatology - IMDS)
  • Primary and/or permanent teeth present

Exclusion criteria

Exclusion Criteria:

Cleft group:

  • Edentulous patients (no teeth)

Control group:

  • Edentulous patients (no teeth)
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
400 participants (estimated)

Study arms

  • Experimental
    Cleft group

    Children and adolescents aged 2 to 18 years with any type of cleft lip and/or palate (with or without an associated syndrome), followed at the Cleft Lip and Palate Centre of the Cliniques universitaires Saint-Luc.

    Other: Clinical oral examination and standardised questionnaires

  • Other
    Control group

    Children and adolescents aged 2 to 18 years without a cleft or syndrome, age-matched (± 1 year) to the cleft group, seen for a routine visit in paediatric dentistry at the Cliniques universitaires Saint-Luc.

    Other: Clinical oral examination and standardised questionnaires

Interventions

  • OtherClinical oral examination and standardised questionnaires

    Single study visit during a routine dental consultation (standard of care), with study-specific standardised assessments: caries experience (dmft/DMFT, recorded tooth by tooth Decayed, Missing, Filled Teeth), enamel defect screening (Ghanim et al. 2015, modified DDE Developmental Defects of Enamel index), and CAMBRA (Caries Management by Risk Assessment). Parents complete standardised questionnaires on the child's medical and dental history, oral hygiene and dietary habits, and early-life factors associated with enamel defects. In the cleft group only, upper lip mobility is assessed with a clinical scale. Intra-oral photographs may be taken. No drug, device or treatment is tested, and no radiographs are taken for study purposes only.

06

What researchers measure

Primary outcomes

  1. Caries experience assessed by the dmft/DMFT index in patients with cleft lip and/or palate compared with age-matched controls

    Caries experience will be assessed by clinical oral examination by a calibrated examiner using the dmft index (decayed, missing and filled primary teeth) and/or the DMFT index (Decayed, Missing and Filled permanent Teeth), according to WHO diagnostic criteria. Scores range from 0 to 20 for dmft and from 0 to 28/32 for DMFT. Higher scores indicate greater caries experience. Mean scores will be compared between children with cleft lip and/or palate and age-matched controls.

    Time frame: Throughout the entire study, approximately during 20 months

Secondary outcomes

  1. Prevalence of developmental defects of enamel in patients with cleft compared with controls

    Time frame: Throughout the entire study, approximately during 20 months

  2. Localisation of developmental defects of enamel assessed by the modified DDE index in patients with cleft compared with controls

    Developmental defects of enamel will be recorded by clinical oral examination by a calibrated examiner using the MIH/HSPM long recording sheet (Ghanim et al., 2015), which includes MIH/HSPM and modified DDE characteristics on all erupted teeth. For each tooth and surface (buccal, occlusal/incisal, palatal/lingual), the defect type will be scored from 0 to 7 (0 = no defect; 1 = non-MIH/HSPM defect: diffuse opacity, hypoplasia, amelogenesis imperfecta, hypomineralisation; 2 = demarcated opacity; 3 = post-eruptive enamel breakdown; 4 = atypical restoration; 5 = atypical caries; 6 = missing due to MIH/HSPM; 7 = cannot be scored). Lesion extent will be graded I to III (\<1/3, 1/3-2/3, ≥2/3 of the surface). Severity will be classified as mild or severe according to EAPD criteria. The distribution of defects by tooth, surface and cleft side will be compared between groups.

    Time frame: Throughout the entire study, approximately during 20 months

  3. Correlation between dietary, oral hygiene and socio-economic factors assessed by the CAMBRA form (Caries Management by Risk Assessment) and caries experience (dmft/DMFT index)

    Risk factors will be recorded using the French version of the CAMBRA caries risk assessment form (Doméjean et al., 2025), age-specific version (0-6 years or \>6 years). Each item is scored as present/absent (yes/no): dietary factors (frequent snacking \>3 times/day; bottle or cup with liquids other than water, 0-6 y), oral hygiene factors (fluoride toothpaste at least twice daily; visible dental plaque) and socio-economic factor (low family socio-economic status and/or low health literacy, 0-6 y). Caries experience will be measured as dmft/DMFT score.

    Time frame: Throughout the entire study, approximately during 20 months

  4. Correlation between upper lip mobility (clinical eversion score 0-3 and photographic lip mobility in mm) and anterior caries experience (dmft/DMFT index) in patients with cleft

    Upper lip mobility will be assessed in the cleft group by two methods: (1) a clinical eversion score from 0 to 3 (0 = normal mobility, full access to labial surfaces of maxillary anterior teeth; 1 = slightly reduced; 2 = moderately reduced, cervical third of incisors hardly accessible; 3 = severely reduced, tense lip, labial surfaces hardly accessible to brushing) (2) standardised peri-oral photographs at rest and at maximal smile, with lip mobility calculated as the difference in incisal exposure (smile minus rest, in mm). Anterior caries experience will be measured as the dmft/DMFT score of maxillary anterior teeth.

    Time frame: Throughout the entire study, approximately during 20 months

07

Study locations

1 site
  • Cliniques universitaires Saint-Luc
    Brussels, Brabant Flamand 1200, Belgium
    • Fanny Deghorain, DDS, MSc (Paediatric Dentistry · Contactfanny.deghorain@uclouvain.be · +32491303966
    • Pierre Mahy, MD, DDS, PhD · Contact
    • Fanny Deghorain, DDS, MSc (Paediatric Dentistry · Sub investigator
    • Pierre Mahy, MD, DDS, PhD · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2026; primary completion for Dec 2027, 12 months later.

Of 469 non-industry interventional studies with no phase under Dental Caries, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's planned 12 months is below that.

Counting every sponsor, half of 502 studies reached it within 15 months; a quarter within 7 and three quarters within 29.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 29, 2026
First posted
Nov 9, 2026
StartEst.
Dec 14, 2026
Primary completionEst.
Dec 31, 2027
CompletionEst.
Jun 30, 2028
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07926646
Responsible party
Sponsor
First posted
Nov 9, 2026
Start date
Dec 14, 2026 (estimated)
Primary completion
Dec 31, 2027 (estimated)
Completion
Jun 30, 2028 (estimated)
Last update
Nov 9, 2026

Study contacts

Fanny Deghorain, DDS, MSc (Paediatric Dentistry
Contact
fanny.deghorain@uclouvain.be
+32491303966

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion